Quantitative appraisal of the Amyloid Imaging Taskforce appropriate use criteria for amyloid-PET 2018 Daniele Altomare, Clarissa Ferrari, Cristina Festari, Ugo P. Guerra, Cristina Muscio, Alessandro Padovani, Giovanni B. Frisoni, Marina BoccardiAlzheimer's and Dementia, pp. -
The CST3 B haplotype is associated with frontotemporal lobar degeneration 2010 L. Benussi, R. Ghidoni, Daniela Galimberti, Marina Boccardi, Chiara Fenoglio, E. Scarpini, Giovanni B. Frisoni, G. BinettiEuropean Journal of Neurology, pp. -
2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework 2021 Antoine Leuzy, Nicholas J. Ashton, N. Mattsson-Carlgren, Alessandra Dodich, Marina Boccardi, J. Corre, Alexander Drzezga, Agneta Nordberg, Rik Ossenkoppele, Henrik Zetterberg, Kaj Blennow, Giovanni B. Frisoni, Valentina Garibotto, Oskar HanssonEuropean Journal of Nuclear Medicine and Molecular Imaging, pp. -
Survey of protocols for the manual segmentation of the hippocampus: Preparatory steps towards a joint EADC-ADNI harmonized protocol 2011 Marina Boccardi, Rossana Ganzola, Martina Bocchetta, Michela Pievani, Alberto Redolfi, George Bartzokis, Richard Camicioli, John G. Csernansky, Mony De Leon, Leyla Detoledo-Morrell, Ronald J. Killiany, Stephane Lehericy, Johannes Pantel, Jens C. Pruessner, Hilkka Soininen, Craig Watson, Simon Duchesne, Clifford R. Jack, Giovanni B. FrisoniJournal of Alzheimer's Disease, pp. -
Amygdaloid atrophy in frontotemporal dementia and Alzheimer's disease 2002 Marina Boccardi, Corina Pennanen, Mikko P. Laakso, Cristina Testa, Cristina Geroldi, Hilkka Soininen, Giovanni B. FrisoniNeuroscience Letters, pp. -